Conformational Response of 30S-bound IF3 to A-Site Binders Streptomycin and Kanamycin
AbstractAminoglycoside antibiotics are widely used to treat infectious diseases. Among them, streptomycin and kanamycin (and derivatives) are of importance to battle multidrug-resistant (MDR) Mycobacterium tuberculosis. Both drugs bind the small ribosomal subunit (30S) and inhibit protein synthesis. Genetic, structural, and biochemical studies indicate that local and long-range conformational rearrangements of the 30S subunit account for this inhibition. Here, we use intramolecular FRET between the C- and N-terminus domains of the flexible IF3 to monitor real-time perturbations of their binding sites on the 30S platform. Steady and pre-steady state binding experiments show that both aminoglycosides bring IF3 domains apart, promoting an elongated state of the factor. Binding of Initiation Factor IF1 triggers closure of IF3 bound to the 30S complex, while both aminoglycosides revert the IF1-dependent conformation. Our results uncover dynamic perturbations across the 30S subunit, from the A-site to the platform, and suggest that both aminoglycosides could interfere with prokaryotic translation initiation by modulating the interaction between IF3 domains with the 30S platform. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 8607 KB)
Share & Cite This Article
Chulluncuy, R.; Espiche, C.; Nakamoto, J.A.; Fabbretti, A.; Milón, P. Conformational Response of 30S-bound IF3 to A-Site Binders Streptomycin and Kanamycin. Antibiotics 2016, 5, 38.
Chulluncuy R, Espiche C, Nakamoto JA, Fabbretti A, Milón P. Conformational Response of 30S-bound IF3 to A-Site Binders Streptomycin and Kanamycin. Antibiotics. 2016; 5(4):38.Chicago/Turabian Style
Chulluncuy, Roberto; Espiche, Carlos; Nakamoto, Jose A.; Fabbretti, Attilio; Milón, Pohl. 2016. "Conformational Response of 30S-bound IF3 to A-Site Binders Streptomycin and Kanamycin." Antibiotics 5, no. 4: 38.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.